2 results
Approved WMOPending
To assess accuracy and reliability of new-to-market CGM systems in patients with type 1 diabetes.
Approved WMOCompleted
Primary Objective:* To evaluate the effect of treatment with omecamtiv mecarbil (OM) compared with placebo on exercise capacity as determined by cardiopulmonary exercise testing (CPET) following 20 weeks of treatment with OM or placeboSecondary…